MSD, Moderna skin cancer vaccine scores historic phase 3 win
MSD, Moderna skin cancer vaccine scores historic phase 3 win
Moderna Therapeutics
Private
Biopharmaceutical company. See news coverage for latest developments.
Company Info
Recent News
Moderna, Merck breakthrough could usher in wave of cancer vaccines, includes video
Moderna, Merck breakthrough could usher in wave of cancer vaccines, includes video
Moderna, Merck vaccine cuts recurrence and spread of melanoma, raising new treatment hope, includes video
Moderna, Merck vaccine cuts recurrence and spread of melanoma, raising new treatment hope, includes video
Moderna shares double as cancer vaccine data rekindles investor hopes
Moderna shares double as cancer vaccine data rekindles investor hopes
VIEW Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results
VIEW Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results
FDA approves Moderna’s mRNA flu vaccine, the first to use the technology
FDA approves Moderna’s mRNA flu vaccine, the first to use the technology